BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 4207590)

  • 21. Consumption of anti-D in the erythroblastotic fetus.
    Gottvall T; Selbing A
    Acta Obstet Gynecol Scand; 1998 May; 77(5):500-3. PubMed ID: 9654170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Studies on the effectiveness of the anti-D-prevention at the Göttingen University Gynecological Clinic from 1969 to 1972].
    Hähn N; Gallasch EH; Wilken H
    Zentralbl Gynakol; 1976; 98(1):39-44. PubMed ID: 814743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rhesus-erythroblastosis. Diagnosis, therapy, prevention].
    Maas DH; Schneider J
    Fortschr Med; 1976 May; 94(13):735-40. PubMed ID: 821837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Anti-D prophylaxis after abortions and interruptions].
    Maas DH
    Fortschr Med; 1979 Jan; 97(4):148-52. PubMed ID: 217809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women.
    Kornstad L
    NIPH Ann; 1987 Jun; 10(1):3-10. PubMed ID: 3116469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Practical experiences with the anti-D-IgG prevention of Rh-immunization].
    Bergmann H; Leinzinger E; Pazdernik I; Haider M
    Wien Med Wochenschr; 1969 Jan; 119(1):9-12. PubMed ID: 4975236
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention of hemolytic disease in newborn infants using anti-D immunoglobulin G].
    Mikulandra F; Perisa M; Merlak I; Kimer M; Glavadanović N
    Zentralbl Gynakol; 1989; 111(7):444-52. PubMed ID: 2786664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention of Rhesus-sensitization by intravenous administration of immunoglobulin G anti-D. II. General prevention using low doses of IgG anti-D, adapted to the extent of fetomaternal transfusion].
    Börner P; Deicher H; Ghani G; Geldmacher H; Kayser D; Kahnt P; Klang D; Klaus H; Marks V; Nehawandian OA
    Geburtshilfe Frauenheilkd; 1971 Oct; 31(10):911-23. PubMed ID: 5002413
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
    David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
    Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of anti-D prevention using the optical mark page reader].
    Alsleben-Tolon J; Bücking J; Schneider J
    Fortschr Med; 1976 Nov; 94(31):1752-6. PubMed ID: 826467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus maternofetal bleeding.
    Scott JR; Beer AE; Guy LR; Liesch M; Elbert G
    Obstet Gynecol; 1977 Jan; 49(1):9-14. PubMed ID: 401536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of Rh isoimmunization.
    Clarke CA
    Prog Med Genet; 1972; 8():169-223. PubMed ID: 4110995
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of Rh isoimmunization. Results of prevention with anti-D IgG].
    Baldini E; Bertaglia A; Strammiello A; Secchi E; Garau S; De Palma M
    Minerva Ginecol; 1978 Mar; 30(3):170-3. PubMed ID: 78474
    [No Abstract]   [Full Text] [Related]  

  • 35. [Prevention of rhesus sensitization using immunoglobulin G anti-D].
    Börner P; Deicher H
    Dtsch Med J; 1969 Aug; 20(15):471-6. PubMed ID: 4898976
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of Rh isoimmunization. Results of prevention with anti D IgG].
    Mega M; Arreghini G; Lunghi F; De Laurentiis G
    Riv Ital Ginecol; 1974 May; 55(3):273-82. PubMed ID: 4211571
    [No Abstract]   [Full Text] [Related]  

  • 38. [The effect of Rh-D immunoprophylaxis with hyperimmune anti-D-immunoglobulin on the occurrence of RhD immunization in pregnancy].
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Lijec Vjesn; 1997 Jul; 119(7):189-93. PubMed ID: 9471477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
    Lubušký M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rho (d) immune globulin (human).
    Med Lett Drugs Ther; 1974 Jan; 16(1):3-4. PubMed ID: 4202567
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.